Le Lézard
Classified in: Health
Subject: CCA

Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results


MARLBOROUGH, Mass., April 1, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 24 prior to the conference call.

A live webcast and replay of the webcast will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter. 

CONTACTS:
Katie Schur
Media Relations
+1 (508) 683-5574 (office)
[email protected]

Jon Monson
Investor Relations
+1 (508) 683-5450
[email protected] 

SOURCE Boston Scientific Corporation


These press releases may also interest you

at 22:30
Monsanto Wins Appeal Ruling in Erickson v. Monsanto
Today, a decision was issued by the Court of Appeals Division I in the State of Washington in Erickson v. Monsanto, ruling in Monsanto's favor on multiple grounds. This decision reverses the initial verdict of $185 million in its entirety and...

at 21:30
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc.  today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a...

at 21:00
Memorial Regional Hospital Named Florida's First Resuscitation Center of Excellence
Memorial Regional Hospital in Florida has earned the prestigious title of being the state's inaugural Resuscitation Center of Excellence (RCOE), underscoring the hospital's adherence to over 30 evidence-based criteria in providing top-tier cardiac...

at 19:31
Momcozy Announces Collaboration with 1 Natural Way To Provide Accessible Breastfeeding Solutions For New Mothers
Momcozy, a trusted global brand specializing in solution-focused maternal and baby care products since 2018, has announced their collaboration with 1 Natural Way (1NW), a nationally recognized Durable Medical Equipment company catering to the precise...

at 19:01
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomicstm antigen discovery technologies to target five more cancers
Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today announced the completion of a...

at 17:49
The ALS Association Kicks Off ALS Awareness Month and Commemorates the 10th Anniversary of the Ice Bucket Challenge
The ALS Association today celebrated the beginning of ALS Awareness Month and the 10th Anniversary of the Ice Bucket Challenge, which inspired the world to join the fight against ALS in the summer of 2014. Throughout May and the summer, the ALS...

More news about Health...


News published on and distributed by: